Long-Term Adherence to Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Comparative Cross-Sectional Study

被引:3
|
作者
Gulpen, Anouk J. W. [1 ,2 ,3 ]
Braeken, Dionne C. W. [1 ]
Schalla, Simon [2 ,4 ]
Ten Cate, Hugo [1 ,2 ,3 ]
Crijns, Harry J. [2 ,4 ]
Ten Cate-Hoek, Arina J. [1 ,2 ]
机构
[1] Maastricht & Lab Clin Thrombosis & Hemostasis, Thrombosis Expert Ctr, Maastricht, Netherlands
[2] Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands
[3] Maastricht Univ, Dept Internal Med, Med Ctr, Maastricht, Netherlands
[4] Maastricht Univ, Med Ctr, Dept Cardiol & Radiol, Maastricht, Netherlands
关键词
Direct oral anticoagulants; Thrombosis; Adherence; WARFARIN; DABIGATRAN; PERSISTENCE; APIXABAN; THERAPY; SCALE;
D O I
10.1159/000524094
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Long-term treatment with direct oral anticoagulants (DOAC) is required for the majority of patients with nonvalvular atrial fibrillation (AF) to prevent ischemic stroke and systemic embolism. Adherence to therapy may impact clinical outcomes. Therefore, the purpose of this study was to assess the potential impact of structured follow-up on long-term adherence to DOAC therapy compared to standard care. Methods: This is a cross sectional study on the implementation phase of medication adherence to DOACs, comparing patients with AF following completion of structured follow-up of minimally 1 year with those who received standard care. All patients used DOACs for more than 2 years and completed a questionnaire on adherence. Adherence was measured with the Morisky Medication Adherence Scale-8 (MMAS-8) score and assessed via an online web portal. Results: A total of 212 patients were included. The mean MMAS-8 score was 7.55 (SD 0.93) after structured follow-up and 7.25 (SD 1.01) for standard care; p = 0.045. Following structured follow-up 64.1% of patients had a high adherence (MMAS score of 8) compared to 50% receiving standard care; p = 0.05. Patients following structured follow-up on a once daily DOAC regime had higher MMAS-8 scores compared to those on a twice daily regime; 7.74 (SD 0.74) versus 7.00 (SD 1.22); p < 0.001. The rates of minor bleedings were 10.6% versus 21.4% respectively, p = 0.038. Conclusion: In patients on long-term DOAC treatment, adherence to therapy was significantly increased after receiving an initial period of structured follow-up compared to standard care. Additionally, adherence to DOAC therapy was higher with once-daily treatment regimen. Significant more minor bleedings were reported in the standard care group. These results indicate that implementation of structured follow-up of patients with AF using DOACs merits further evaluation. (c) 2022 The Author(s). Published by S. Karger AG, Basel
引用
收藏
页码:476 / 483
页数:8
相关论文
共 50 条
  • [21] Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration
    Borne, Ryan T.
    O'Donnell, Colin
    Turakhia, Mintu P.
    Varosy, Paul D.
    Jackevicius, Cynthia A.
    Marzec, Lucas N.
    Masoudi, Frederick A.
    Hess, Paul L.
    Maddox, Thomas M.
    Ho, P. Michael
    BMC CARDIOVASCULAR DISORDERS, 2017, 17
  • [22] The treatment pattern and adherence to direct oral anticoagulants in patients with atrial fibrillation aged over 65
    Han, Sola
    Jeong, Hwa Seop
    Kim, Hyungtae
    Suh, Hae Sun
    PLOS ONE, 2019, 14 (04):
  • [23] Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
    Zielinski, Gilda D.
    van Rein, Nienke
    Teichert, Martina
    Klok, Frederikus A.
    Rosendaal, Frits R.
    van der Meer, Felix J. M.
    Huisman, Menno V.
    Cannegieter, Suzanne C.
    Lijfering, Willem M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (08) : 1027 - 1036
  • [24] Assessment of adherence, treatment satisfaction and knowledge of direct oral anticoagulants in atrial fibrillation patients
    Moudallel, Souad
    van Laere, Sven
    Cornu, Pieter
    Dupont, Alain
    Steurbaut, Stephane
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (05) : 2419 - 2429
  • [25] Vitamin K Antagonists and Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation
    Raposeiras-Roubin, Sergio
    Alonso Rodriguez, David
    Camacho Freire, Santiago Jesus
    Abu-Assi, Emad
    Cobas-Paz, Rafael
    Rodriguez Pascual, Carlos
    Garcia Comesana, Julio
    Gonzalez-Carrero Lopez, Alberto
    Cubelos Fernandez, Naiara
    Lopez-Masjuan Rios, Alvaro
    Cespon-Fernandez, Maria
    Munoz-Pousa, Isabel
    Caneiro-Queija, Berenice
    Rodriguez Albarran, Adrian
    Alvarez Castanera, Sara
    Verisimo Guillen, Julia
    Carpintero Vara, Alberto
    Barreiro Pardal, Cristina
    Dominguez-Erquicia, Pablo
    Manuel Dominguez-Rodriguez, Luis
    Diaz Fernandez, Jose Francisco
    Fernandez Vazquez, Felipe
    Iniguez-Romo, Andres
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2020, 21 (03) : 367 - +
  • [26] Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation
    Jackevicius, Cynthia A.
    Lu, Lingyun
    Ghaznavi, Zunera
    Warner, Alberta L.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2021, 14 (02): : 155 - 168
  • [27] Medium- to long-term persistence with non-vitamin-K oral anticoagulants in patients with atrial fibrillation: Australian experience
    Simons, Leon A.
    Ortiz, Michael
    Freedman, Ben
    Waterhouse, Benjamin J.
    Colquhoun, David
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (07) : 1337 - 1341
  • [28] Efficacy and Safety Outcomes of Direct Oral Anticoagulants and Amiodarone in Patients with Atrial Fibrillation
    Lupercio, Florentino
    Romero, Jorge
    Peltzer, Bradley
    Maraboto, Carola
    Briceno, David
    Villablanca, Pedro
    Ferrick, Kevin
    Gross, Jay N.
    Kim, Soo
    Fisher, John
    Di Biase, Luigi
    Krumerman, Andrew
    AMERICAN JOURNAL OF MEDICINE, 2018, 131 (05) : 573.e1 - 573.e8
  • [29] Label Adherence of Direct Oral Anticoagulants Dosing and Clinical Outcomes in Patients With Atrial Fibrillation
    Yu, Hee Tae
    Yang, Pil-Sung
    Jang, Eunsun
    Kim, Tae-Hoon
    Uhm, Jae-Sun
    Kim, Jong-Youn
    Pak, Hui-Nam
    Lee, Moon-Hyoung
    Lip, Gregory Y. H.
    Joung, Boyoung
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (12):
  • [30] Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation
    Shah, Surbhi
    Norby, Faye L.
    Datta, Yvonne H.
    Lutsey, Pamela L.
    MacLehose, Richard F.
    Chen, Lin Y.
    Alonso, Alvaro
    BLOOD ADVANCES, 2018, 2 (03) : 200 - 209